home / stock / slgc / slgc quote
Last: | $2.10 |
---|---|
Change Percent: | -2.86% |
Open: | $2.16 |
Close: | $2.10 |
High: | $2.31 |
Low: | $1.93 |
Volume: | 33,910,799 |
Last Trade Date Time: | 01/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$2.1 | $2.16 | $2.1 | $2.31 | $1.93 | 33,910,799 | 01-05-2024 |
$2.2 | $2.28 | $2.2 | $2.3 | $2.155 | 4,455,197 | 01-04-2024 |
$2.29 | $2.44 | $2.29 | $2.44 | $2.25 | 3,076,969 | 01-03-2024 |
$2.45 | $2.57 | $2.45 | $2.67 | $2.42 | 1,860,885 | 01-02-2024 |
$2.53 | $2.69 | $2.53 | $2.74 | $2.51 | 1,605,036 | 01-01-2024 |
$2.53 | $2.69 | $2.53 | $2.74 | $2.51 | 1,605,036 | 12-29-2023 |
$2.66 | $2.56 | $2.66 | $2.68 | $2.53 | 2,419,929 | 12-28-2023 |
$2.53 | $2.47 | $2.53 | $2.57 | $2.42 | 1,949,138 | 12-27-2023 |
$2.47 | $2.36 | $2.47 | $2.485 | $2.25 | 1,933,181 | 12-26-2023 |
$2.3 | $2.22 | $2.3 | $2.39 | $2.21 | 3,746,522 | 12-25-2023 |
$2.3 | $2.22 | $2.3 | $2.39 | $2.21 | 3,746,522 | 12-22-2023 |
$2.2 | $2.08 | $2.2 | $2.22 | $2.05 | 1,941,050 | 12-21-2023 |
$2.12 | $2.27 | $2.12 | $2.295 | $2.11 | 1,950,057 | 12-20-2023 |
$2.28 | $2.18 | $2.28 | $2.29 | $2.12 | 1,908,314 | 12-19-2023 |
$2.125 | $2.1 | $2.125 | $2.195 | $2.08 | 1,337,307 | 12-18-2023 |
$2.11 | $2.48 | $2.11 | $2.48 | $2.1 | 2,836,313 | 12-15-2023 |
$2.41 | $2.55 | $2.41 | $2.55 | $2.39 | 2,428,915 | 12-14-2023 |
$2.48 | $2.4 | $2.48 | $2.55 | $2.39 | 2,976,385 | 12-13-2023 |
$2.42 | $2.5 | $2.42 | $2.5 | $2.3 | 1,841,445 | 12-12-2023 |
$2.4 | $2.42 | $2.4 | $2.51 | $2.35 | 1,669,734 | 12-11-2023 |
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health , today announced that its stockholders voted to approve all proposals required to be approved in...
SomaLogic Stockholders Vote to Approve Standard BioTools Transaction at Special Meeting PR Newswire Stockholder Approval Represents Key Milestone Toward Completion of Standard BioTools Transaction Combination Will Create a Diversified Leader in Life Sciences Tools ...
Believes All SomaLogic Directors – Robert Barchi , Thomas Carey , Eli Casdin , Troy Cox , Kathy Hibbs , Anne Margulies , Tycho Peterson , Richard Post and Jason Ryan – Have Betrayed Shareholders by Delaying the Special Meeting Five Times so the Bo...